COM:ICOSAVAX
Icosavax, Inc.
- Stock
Last Close
15.45
16/02 21:00
Market Cap
769.04M
Beta: -
Volume Today
8.56M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
---|---|---|---|---|---|
average inventory | |||||
average payables | 1.36M - | 2.91M 114.10% | 3.40M 16.74% | ||
average receivables | |||||
book value per share | -0.80 - | -9.28 1,052.61% | 15.49 266.91% | 5.49 64.54% | |
capex per share | -0.00 - | -0.06 1,365.12% | -0.28 399.59% | ||
capex to depreciation | -11 - | -12.27 11.53% | -12.92 5.33% | ||
capex to operating cash flow | 0.00 - | 0.03 3,271.53% | 0.18 590.30% | ||
capex to revenue | |||||
cash per share | 2.25 - | 4.56 102.17% | 15.53 240.93% | 5.50 64.62% | |
days of inventory on hand | |||||
days payables outstanding | |||||
days sales outstanding | |||||
debt to assets | 0.31 - | 0.04 - | |||
debt to equity | -0.19 - | 0.04 - | |||
dividend yield | |||||
earnings yield | -0.01 - | -0.19 1,213.71% | -0.17 13.21% | -0.28 69.53% | |
enterprise value | 335.03M - | 92.48M 72.40% | 131.98M 42.71% | 265.37M 101.07% | |
enterprise value over ebitda | -62.07 - | -4.94 92.04% | -2.03 58.86% | -2.79 37.28% | |
ev to operating cash flow | -73.33 - | -6.51 91.12% | -3.42 47.39% | -4.30 25.65% | |
ev to sales | |||||
free cash flow per share | -0.45 - | -4.94 1,007.28% | -2.20 55.44% | -1.83 16.76% | |
free cash flow yield | -0.01 - | -0.14 1,007.28% | -0.10 31.90% | -0.23 139.87% | |
graham net net | -0.83 - | -10.34 1,152.76% | 15.01 245.17% | 4.98 66.83% | |
graham number | 3.03 - | 37.30 1,130.53% | 36.32 2.65% | 16.59 54.32% | |
income quality | 0.86 - | 0.75 12.63% | 0.58 23.63% | 0.67 16.80% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | |
interest coverage | -56.53 - | -436.17 671.62% | 28.81 106.60% | ||
interest debt per share | 1.83 - | 0.01 99.54% | 0.14 1,545.79% | ||
inventory turnover | |||||
invested capital | -0.19 - | 0.04 - | |||
market cap | 358.11M - | 100.65M 71.89% | 411.06M 308.41% | 315.42M 23.27% | |
net current asset value | -8.24M - | -26.71M 224.07% | 277.14M 1,137.49% | 203.40M 26.61% | |
net debt to ebitda | 4.28 - | 0.44 89.79% | 4.30 885.06% | 0.53 87.76% | |
net income per share | -0.51 - | -6.67 1,213.71% | -3.78 43.22% | -2.23 41.17% | |
operating cash flow per share | -0.45 - | -4.94 1,006.42% | -2.15 56.54% | -1.55 27.63% | |
payables turnover | |||||
receivables turnover | |||||
research and ddevelopement to revenue | |||||
return on tangible assets | -0.22 - | -1.19 431.76% | -0.24 80.07% | -0.37 56.77% | |
revenue per share | |||||
roe | 0.63 - | 0.72 13.98% | -0.24 134.02% | -0.41 65.90% | |
roic | 0.64 - | 0.88 36.23% | -0.24 127.47% | -0.39 61.72% | |
sales general and administrative to revenue | |||||
shareholders equity per share | -0.80 - | -9.28 1,052.61% | 15.49 266.91% | 5.49 64.54% | |
stock based compensation to revenue | |||||
tangible asset value | -8.24M - | -26.70M 223.95% | 278.22M 1,141.91% | 218.16M 21.59% | |
tangible book value per share | -0.80 - | -9.28 1,052.61% | 15.49 266.91% | 5.49 64.54% | |
working capital | 22.07M - | 10.33M 53.20% | 277.31M 2,585.60% | 210.13M 24.23% |
All numbers in USD (except ratios and percentages)